Ticker Launch
Sign inTry it free

IPO · AXLA

Axcella Health Inc.

Formerly Pronutria Biosciences, Inc.

Axcella Health Inc. (AXLA) priced its initial public offering on May 9, 2019 at $20.00 per share, within its $20.00–$22.00 range, raising $71.4M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $459.8M. Goodwin Procter advised the company and Latham & Watkins advised the underwriters.

Axcella Health Inc. is a biotechnology company developing orally administered AXA Candidates, which are compositions of endogenous metabolic modulators anchored by amino acids, to address dysregulated metabolism in consumers and patients. They are generated from the company's proprietary AXA Development Platform.

Status
IPO
Ticker
AXLA
Exchange
Nasdaq Global Market
Priced
May 9, 2019
IPO price
$20.00
Price range
$20.00–$22.00
Raised
$71.4M
Market cap at IPO price
$459.8M
First filed
Apr 12, 2019
Company counsel
Goodwin Procter
Underwriters' counsel
Latham & Watkins
Sector
Biotech & pharma
Country / state
MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Biotech & pharma IPOs in 2019